Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 7.2B | 6.8B | 8.1B |
Cost of revenue | 7.1B | 5.8B | 5.2B | 6.2B |
Gross profit | 2.0B | 1.4B | 1.6B | 1.9B |
Operating expense | ||||
Research & development | 293.9M | 376.2M | 281.0M | 263.8M |
Selling general and admin | 823.5M | -986.2M | 1.7B | 99.2M |
Other operating expenses | 42.5M | 83.4M | 43.9M | 39.1M |
Operating income | 912.8M | 332.9M | 468.5M | 781.6M |
Non operating interest income | ||||
Income | 54.7M | 55.3M | 57.2M | 65.3M |
Expense | 78.0M | 64.6M | 73.0M | 83.3M |
Other income expense | — | — | — | — |
Pretax income | 802.4M | 79.2M | 363.7M | 560.0M |
Tax provision | 159.0M | 50.1M | 22.7M | 58.8M |
Net income | 643.4M | 29.2M | 341.0M | 501.2M |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 2.0B | — | — | — |
Diluted average shares | 2.3B | — | — | — |
EBITDA | 1.0B | 327.0M | 523.4M | 866.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | 13.8M | -22.7M | -3.9M | -15.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |